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Abstract
Background: The HNF1A, HNF1B and HNF4A genes are part of an autoregulatory network in mammalian pancreas, liver,
kidney and gut. The layout of this network appears to be similar in rodents and humans, but inactivation of HNF1A, HNF1B
or HNF4A genes in animal models cause divergent phenotypes to those seen in man. We hypothesised that some
differences may arise from variation in the expression profile of alternatively processed isoforms between species.
Methodology/Principal Findings: We measured the expression of the major isoforms of the HNF1A, HNF1B and HNF4A
genes in human and rodent pancreas, islet, liver and kidney by isoform-specific quantitative real-time PCR and compared
their expression by the comparative Ct (DDCt) method. We found major changes in the expression profiles of the HNF genes
between humans and rodents. The principal difference lies in the expression of the HNF1A gene, which exists as three
isoforms in man, but as a single isoform only in rodents. More subtle changes were to the balance of HNF1B and HNF4A
isoforms between species; the repressor isoform HNF1B(C) comprised only 6% in human islets compared with 24–26% in
rodents (p = 0.006) whereas HNF4A9 comprised 22% of HNF4A expression in human pancreas but only 11% in rodents
(p = 0.001).
Conclusions/Significance: The differences we note in the isoform-specific expression of the human and rodent HNF1A,
HNF1B and HNF4A genes may impact on the absolute activity of these genes, and therefore on the activity of the pancreatic
transcription factor network as a whole. We conclude that alterations to expression of HNF isoforms may underlie some of
the phenotypic variation caused by mutations in these genes.
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Introduction
The hepatocyte nuclear factors genes, which code for a family of
tissue-specific transcription factors, represent one group which
exhibit phenotypic divergence between rodent and man. In
humans, heterozygous mutations in the genes coding for the
HNF1 homeobox A (HNF1A), hepatocyte nuclear factor -4 alpha
(HNF4A) and HNF1 homeobox B (HNF1B) genes cause maturity-
onset diabetes of the young subtypes HNF1A-MODY and HNF4A-
MODY, and the renal cysts and diabetes (RCAD) syndrome
respectively. MODY is characterised by progressive beta-cell
failure and an inability to increase insulin secretion in response to
hyperglycaemia [1], whereas RCAD is characterised by renal
cystic disease, young-onset diabetes, pancreatic atrophy, abnormal
liver function tests, and in some cases genital tract abnormalities
[2].
Homozygous germline HNF1A, HNF1B or HNF4A mutations
have not been found in humans [2,3]; their associated phenotypes
manifest in heterozygous state, whereas mice carrying only one
defective copy of the HNF1A or HNF4A gene show no defects in
glycolytic signalling or renal glucose reabsorption as do their
human counterparts [4–6]. Similarly, the beta cell-specific
conditional knockout mouse is only hyperglycaemic during an
intraperitoneal glucose tolerance test, whereas RCAD patients
have fasting plasma hyperglycemia [7]. These animals also
demonstrate no decrease in insulin sensitivity upon glucose
challenge when compared to wild-type littermates [8], whereas
RCAD patients are insulin resistant [9]. HNF4A knockout mice
demonstrate altered cholesterol and triglyceride profiles [10],
whereas studies of these parameters in human HNF4A-MODY
patients have been conflicting [11,12].
Several factors may contribute to the differences in phenotype
between the animal models, and human MODY/RCAD patients.
Firstly, phenotypic may arise from the timing of gene knockout in
the animal models. In the case of the HNF1B gene, the conditional
deletion was been carried out in adult (or at least partly
differentiated) mouse islets, since the insulin gene was used to
target the beta cells for gene knockout [8]. The majority of the
developmental effects requiring HNF-1b activity would thus have
occurred prior to gene knockout, whereas developing islets in
RCAD patients would have been exposed to the effects of the
mutation from fertilization. Secondly, since MODY is known to be
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a disorder of haploinsufficiency [13,14], we cannot rule out the
possibility that there may also be species-specific differences in the
dosage of the HNF1A, HNF1B and HNF4A gene products that are
required for full function.
Variation in expression could be also generated by species-
specific differences in the amount and nature of mRNA
transcripts produced. Although some alternate mRNA processing
events are conserved between species, it has been suggested that a
significant number of genes which are known to be alternatively
processed in man, do not produce multiple isoforms in rodents
[15]. In man, the HNF1A, HNF1B and HNF4A genes produce
three, three and nine isoforms respectively by a combination of
alternate promoter usage, alternate splicing and differential use
of polyadenylation sites; figures 1a–1c [16–18]. Although the
existence of some of these isoforms have been noted in rodents
[19–21], to date there has been no systematic comparison of their
spatial expression patterns between rodents and man. We
therefore aimed to compare the expression patterns of HNF1A,
HNF1B and HNF4A isoforms in mouse, rat and human islet, total
pancreas, liver and kidney. Differences between species in the site
and level of expression may help to explain the phenotypic
differences seen in HNF gene knockout animal models and
those observed in HNF1A-MODY, RCAD and HNF4A-MODY
patients.
Results
Validation of Real-Time PCR for the Detection and
Quantification of Alternatively Spliced Transcripts
Real-time PCR assays for human HNF1B isoforms and mouse
and rat HNF1A, HNF1B and HNF4A isoforms all proved
quantitative across a dynamic range of more than seven 1:2 serial
dilutions, with efficiencies of detection ranging from 23.24 to
23.79. The correlations between the crossing point and input
template (r2 value) were also good with r2 values all above 0.90.
Human HNF1A and HNF4A assays have been previously
published [16,17].
Expression Profile of the Human, Mouse and Rat HNF1A
Gene
The human HNF1A gene produces three isoforms; HNF1A(A),
HNF1A(B) and HNF1A[C], but in both rodent species the
HNF1A(A) transcript was essentially the only isoform expressed
in islet, pancreas, liver and kidney. The HNF1A(B) and HNF1A(C)
transcripts were present but never comprising more than 3% of
the rodent HNF1A transcriptome (figure 2a–2d). In all species,
HNF1A expression was highest in islet and pancreas, and lowest in
liver and kidney (figure 2a–2d). Levels of HNF1A(A) were
markedly higher in rodent tissues than in human tissues.
Expression Profile of the Human, Mouse and Rat HNF1B
Gene
Both human and rodent HNF1B genes produce three isoforms;
HNF1B(A), HNF1B(B) and HNF1B(C) (figure 3a–3d). Rodent islets
expressed less HNF1B(A) relative to human islets; comprising 50%
and 49% of total HNF1B expression in mice and rats respectively,
compared to 69% in man (figure 3a; p = 0.004). Rodent islets also
had proportionally more HNF1B(C) than human islets (16 and
26% for mouse and rat respectively v/s 6% for human; p = 0.006).
Overall HNF1B(B) was the predominant isoform in human
pancreas (figure 3b), whereas in mouse, it was less abundant
(44% in man v/s 9 and 31% in mouse and rat; p = 0.003,
figure 3b). Although HNF1B was expressed only at low levels in
liver, the HNF1B(A):HNF1B(B) balance is also altered in rodents
compared with man (figure 3c). Rodent liver had proportionally
more HNF1B(A); comprising 65 and 64% total HNF1B expression
in mouse and rat liver respectively compared with 36% in man
(p = 0.04).
Expression Profile of the Human, Mouse and Rat HNF4A
Gene
We detected a total of six HNF4A isoforms in man, mouse and
rat (figure 4a–4d). As noted for HNF1A transcripts, levels of
HNF4A isoforms were markedly higher in rodent tissues than in
human tissues. In rodent pancreatic and islet tissue, HNF4A
expression was driven from the P2 promoter as it is in man
(Figure 4a and 4b). In human and rat, HNF4A7, and HNF4A8
transcripts were present in approximately equal quantities in islets,
whereas the HNF4A8 transcript was more prevalent in mouse,
comprising 66% of HNF4A expression compared with 46% in
human islet and 43% in rat; p = 0.003 (figure 4a). HNF4A9
transcripts comprised a minor transcript in rodent islets, as in
human islets [17], although levels were slightly higher in rat
comprising 22% of total islet HNF4A expression compared with
9% in man and 4% in mouse; p = 0.006. Human pancreatic tissue
maintained the equal balance of HNF4A7 to HNF4A8 transcripts,
comprising 36 and 42% of total HNF4A expression respectively
(figure 4b), whereas both rat and mouse pancreas demonstrated
Figure 1. Alternatively processed forms of the HNF1A, HNF1B
and HNF4A genes. The structure of alternately processed isoforms of
the HNF1A (1a), HNF1B (1b) and HNF4A (1c) genes is given. Exons are
indicated in gray and numbered, and isoform-specific novel coding
regions in black. The position of the isoform-specific probes are given
by black bars.
doi:10.1371/journal.pone.0007855.g001
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higher levels of the HNF4A8 transcript which comprised 80% and
60% of total HNF4A expression in mouse and rat respectively
compared with 42% in humans (p = 0.002). Human pancreas also
contained more HNF4A9 transcript, relative to rodent pancreas
(figure 4b; 22% in the human v/s 0 and 11% in mouse and rat
respectively; p= 0.001). Transcripts from the P1 promoter also
demonstrated species-specific differences in expression profile. In
mouse liver, we found HNF4A1 transcripts to be more common
in mouse than in humans or rats (present at 63% in mice v/s 37%
in human and 42% in rat; p = 0.05) (figure 4c). We also noted that
HNF4A3 expression was higher in human liver relative to rodent
liver (17% v/s 0% in mouse and 1% total HNF4A expression in
rat; p = 0.027). This was also evident in human kidney, compared
to rodent kidney (figure 4d; HNF4A3 comprising 16% of total
HNF4A expression in human, v/s 0% in mouse and 3% in rat;
p = 0.039).
Effect of Dietary Fat and Carbohydrate on HNF Profiles in
Rodent Liver
Differences in the HNF expression profile between species could
arise from differences in the nature of the nutrient intake in rodent
and human subjects. As we were not able to define these precisely,
we assessed the possible effect of increased fat and reduced
carbohydrate intake on the profile of HNF isoforms in rat liver.
We found that dietary manipulation caused no differences in
either the level or pattern of HNF1A, HNF1B or HNF4A gene
expression.
Discussion
We have identified significant differences in the expression
profiles of the HNF1A, HNF1B and HNF4A genes between human
and rodent species. The major difference we identified is in the
expression of the rodent and human HNF1A genes, which code for
three isoforms in humans, but was expressed as a sole isoform,
HNF1A(A) in all tissues tested in rodents. One potential
explanation for the lack of expression of HNF1A(B) and HNF1B(C)
in rodent tissues may lie in sequence divergence from the human
sequences in rodents in the area surrounding the polyadenylation
signal. The human HNF1A(B) and HNF1A(C) isoforms utilize the
same variant polyadenylation signal (AACAGA) [18], which is not
present in the mouse or rat HNF1A genomic sequence. Thus, once
transcribed, the partially-processed HNF1A(B) or HNF1A(C)
transcripts would lack a poly-A tail, and thus be unstable.
We also detected more subtle differences in HNF1B and HNF4A
profiles, particularly in the relative balance of HNF4A7 and
HNF4A8 transcripts in the pancreas, and the greater abundance of
HNF4A3 and HNF4A9 in human tissues. It is possible that that the
differences we note could arise from alterations in the profile of
HNF1A, HNF1B or HNF4A expression in response nutritional
differences between man and rodent, but we found no evidence to
suggest that high fat intake or reduced carbohydrate intake
influence the HNF profiles.
Our HNF1B results also highlight some interesting differences.
Previous studies have indicated that HNF1B expression is highest
in the kidney and lowest in the liver. Our results indicate that both
Figure 2. The expression profile of the HNF1A gene in human, mouse and rat. The expression profile of the HNF1A gene in human, mouse
and rat is given. The species is given on the X-axis and the relative quantification of each isoform relative to the B2M gene is given on the Y-axis. Each
transcript is normalized to the levels of human HNF1A(A) in each tissue. HNF1A(A) is given by black bars, HNF1A(B) by grey bars and HNF1A(C) by white
bars. Error bars indicate the upper and lower limits of transcript expression. a. islet, b. pancreas, c. liver, d. kidney.
doi:10.1371/journal.pone.0007855.g002
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liver and islets contain significant amounts of HNF1B mRNA
(Figure 3a–d). The reasons for this discrepancy are unclear. There
are also indications that the HNF1B gene may be under post-
transcriptional regulation; previous reports have suggested that
although human islets contain significant amounts of HNF1B
mRNA, levels of HNF-1b in these tissues are barely detectable
[22]. This may indicate targeting of HNF1B by small regulatory
RNA species such as microRNAs.
HNF-1a, HNF-1b and HNF-4a proteins have key roles in
embryonic development and in mature homeostasis. These factors
exist in a tightly regulated feedback circuit in most tissues with
expression, although the precise nature of co-operative regulation
may differ between tissues [23]. Therefore, even subtle differences
in the relative activity of any of these genes may have profound
consequences overall network activity. The relative balance of
isoforms may be crucial, since the structural differences between
transcripts result in proteins with different properties. Since HNF-
1a and HNF1b act as dimers, even small amounts of the variant
isoforms could modify total activity in vivo. The HNF1B(A) and
HNF1B(B) isoforms are very similar in structure and could
therefore demonstrate functional redundancy. Differences in their
relative expression levels between species may not therefore have
physiological consequences. However, the higher levels of the
repressor molecule, HNF1B(C) we note in rodent islets compared
to human islets, could potentially lead to lower relative HNF-1b
activity levels in rodents. The presence of a sole HNF1A isoform in
rodents may suggest that HNF1A(B) and HNF1A(C) are not
absolutely necessary for function in rats and mice. However, our
previous data suggests that HNF1A(B), HNF1A(C), HNF4A3 and
HNF4A9 may have an important role in human beta cell function
since their presence can modify MODY phenotype [16,17].
MODY and RCAD are autosomal dominant disorders, thought
to be mediated by a haploinsufficiency-based mechanism due to a
reduced amount of HNF-1a, HNF-1b or HNF-4a proteins
[13,14]. The levels of HNF transcription factors present in normal
tissue are therefore likely to have an influence on the phenotype
produced by inactivity of one or more alleles. Our finding that the
overall levels of HNF1A and HNF4A transcripts were higher in
rodent tissues than human tissues may therefore have significance.
Since the absolute dosage of the genes in question is crucial,
differences to the overall levels of these genes, regardless of isoform
profiles, may also have an effect. It may prove to be the case that
levels of HNF-1a and HNF-4a are sufficiently high in most mouse
and rat tissues that they are above the threshold needed for
exhibition of disease phenotype in these animal models.
The differences in HNF1A, HNF1B and HNF4A expression in
normal human and rodent tissues has the potential to lead to
subtle alterations activity of the transcription factor network.
Under normal conditions, human and rodent tissues may not
exhibit significant physiological differences. However, species-
specific differences in phenotype may become apparent when the
system is challenged by alterations to the transcription factor
network, either through gene mutation or knockout.
We present here the first direct comparison of the expression
patterns of the HNF1A, HNF1B and HNF4A genes in human and
rodent species. These findings represent an important difference in
mRNA processing of the HNF genes between rodents and man.
We therefore hypothesise that some of the phenotypic differences
Figure 3. The expression profile of the HNF1B gene in human, mouse and rat. The expression profile of the HNF1B gene in human, mouse
and rat is given. The species and transcript identity identity is given on the X-axis and the relative quantification of each isoform relative to the B2M
gene is given on the Y-axis. Each transcript is normalized to the levels of human HNF1A(A) in each tissue. Error bars indicate the upper and lower
limits of transcript expression. a. islet, b. pancreas, c. liver, d. kidney.
doi:10.1371/journal.pone.0007855.g003
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between human MODY and the animal models may arise from
alterations to the activity of the transcription factor network
between species resulting from differential mRNA processing.
Methods
RNA Samples
RNA samples were obtained from kidney (pooled from six
Caucasian females, 28 – 52 yrs), liver (pooled from two male
Caucasians 51 and 64 yrs), pancreas (pooled from five male and
female Caucasians, 24 to 77 yrs) (Clontech, Oxford, UK), and
isolated human islets (two male Caucasians 40 and 56 yrs) (NDRI,
Philadelphia, USA) and have previously been profiled for the
HNF1A and HNF4A genes [16,17]. All human samples were from
non-diabetic individuals who had died as a result of trauma.
Pooled rodent liver, kidney and total pancreas RNAs were from
Wistar rats, aged 7–13 weeks or BALB/C mice aged 3–8 weeks
old (AMS biotechnologies, Oxon, UK). Pooled mouse islet RNA
was derived from NMRI mice aged 12–28 weeks old (n = 4).
Pooled rat islet RNA was the gift of Professor Noel Morgan, and
was derived from male Wistar rats (n = 6; 180–220 g). All animals
had been fed on a standard chow diet. To determine whether
dietary intake could have an effect on the expression of HNF
isoforms, we also tested RNA from 12–18 week old Wistar rats fed
for 10 weeks on either a standard diet (69% carbohydrate, 19%
protein, 11% fat, 6.1% sat. fat; n = 3) or on a high fat diet (35%
carbohydrate, 20% protein, 45% fat, 17.8% sat. fat; n = 4). RNA
samples were DNAse treated prior to reverse transcription using
the TURBO DNAse kit (Ambion, Huntingdon, UK).
Real-Rime PCR Assay Development
Assays to human HNF1A and HNF4A isoforms were previously
published [16,17]. Assays to the three human HNF1B isoforms
were designed to the reference sequences (available from http://
www.ncbi.nlm.nih.gov). Assays to rodent HNF1A, HNF1B and
HNF4A isoforms were designed from sequence alignments of the
rat, mouse and human genes according to the Santa Cruz genome
browser (http://genome.cse.ucsc.edu/cgi-bin/hgGateway). Prim-
er and probe sequences are given in table 1. Real-time PCR assays
were obtained from Applied Biosystems (Foster City, USA). The
ubiquitously expressed beta-2Microglobulin (b2M) gene was selected
as an endogenous control on the basis that its expression does not
differ between the tissues studied, according to publically-available
expression data. Assays for this gene (human: Hs00187842_m1,
mouse: Mm00437764_m1, rat: Rn00560865_m1) were obtained
from Applied Biosystems (Foster City, USA). Assays were validated
as previously described [16,17].
Quantitative Real-Time PCR
Real-time PCR reactions were carried out in triplicate using the
ABI Prism 7900HT platform (Applied Biosystems) and contained
5 ml TaqMan Fast Universal Mastermix (no AMPerase) (Applied
Biosystems, Foster City, USA), 0.9 mM each primer, 0.25 mM
probe and 2 ml cDNA reverse transcribed as above in a total
volume of 10 ml. PCR conditions were a single cycle of 95uC for
20 seconds followed by 50 cycles of 95uC for 1 second and 60uC
for 20 seconds. The relative expression level of each isoform was
then determined relative to the B2M transcript by the comparative
Figure 4. The expression profile of the HNF4A gene in human, mouse and rat. The expression profile of the HNF4A gene in human, mouse
and rat is given. The species and transcript identity is given on the X-axis and the relative quantification of each isoform relative to the B2M gene is
given on the Y-axis. Each transcript is normalized to the levels of human HNF1A(A) in each tissue. Error bars indicate the upper and lower limits of
transcript expression. a. islet, b. pancreas, c. liver, d. kidney.
doi:10.1371/journal.pone.0007855.g004
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(DDCt) method [24]. Transcript abundance was normalized to
human HNF1A(A) transcript present in each tissue. The expression
profiles of the mouse and rat HNF1A, HNF1B and HNF4A genes
were then compared with the corresponding profile in the human
[16,17].
Statistics
All statistical analyses were carried out on pooled samples and
measurements thus represent assay replicates rather than biolog-
ical variation in these samples, which is a limitation of this study.
Apparent differences in expression levels between species were
tested for statistical significance using a three way comparison of
the DDCt values for the test transcript in each species by Kruskal-
Wallis test. Pairwise comparisons were achieved using Mann
Whitney-U test.
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Mouse HNF4A(3/9)P 596FAM – CATGCATTACAGACCTCC – MGB 39
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